YESINTEK

Biocon

Formula & Concentration

YESINTEK – ustekinumab-kfce 130 mg/26 mL intravenous solution

Manufacturer

Biocon Biologics Inc.

Indications

YESINTEK – ustekinumab-kfce 130 mg/26 mL intravenous solution

Product Options

Package Size

NDC #

Presentation

130 MG/26 ML

83257-0026-11

VIAL

45 MG/0.5 ML

83257-0023-41

SYRINGE

45 MG/0.5 ML

83257-0024-11

VIAL

90 MG/ML

83257-0025-41

SYRINGE

Shelf Life and Storage

Fridge (2-8°C)